Renub

    Vitiligo Treatment Market, Size, Share, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis

    Excel: 8 Hours
    PDF: 24 Hours
    Aug 2023
    Pages: 250

    Vitiligo Treatment Market Outlook

    Vitiligo Treatment Market size will be US$ 822.75 Million by 2028, according to Renub Research. Vitiligo, a prevalent skin condition affecting around 70 million individuals globally, stems from the immune-triggered deterioration of melanocytes. The most prevalent subtype, non-segmental vitiligo, typically follows a chronic trajectory and often inflicts notable psychosocial ramifications on sufferers. Timely identification, awareness of associated conditions, accurate gauging of disease scope and intensity, scrutiny of quality-of-life impairments, and swift implementation of treatment grounded in current evidence-based practices are pivotal pillars in vitiligo management. Notably, 20–35% of patients are children. In July 2022, the FDA's green lighting of the 1.5% ruxolitinib cream marked a significant milestone as the first topical solution for non-segmental vitiligo in individuals aged 12 and above, providing gratifying results for dedicated vitiligo advocates.

     

    Global Vitiligo Treatment Market Size, 2023-2028 (Billion US$)

     

    global-vitiligo-market

     

    Note: The chart above shows dummy data and is only for illustration purposes. Please get in touch with us for the actual market size and trends.


    Vitiligo Treatment Market is growing at a CAGR of 4.96% from 2022 to 2028

    The escalating global prevalence of vitiligo is a driving force behind market expansion, as an increasing number of individuals receive diagnoses. Progress in treatment alternatives, encompassing topical medications, phototherapy, and surgical interventions, empowers patients with diversified options and enhanced outcomes. Heightened cognizance of vitiligo within both medical circles and the public sphere facilitates prompt identification and intervention, propelling the need for therapeutic approaches and management tactics.

    Ongoing research delves into vitiligo's origins and novel treatments, advancing the market. Advocacy groups support companies, offering resources and improving accessibility. Technological advancements, like lasers and drug delivery, enhance treatment. Its aesthetic impact drives demand for cosmetics like makeup and pigments. Vitiligo Treatment Market has reached US$ 615.2 Million in 2022.


    New pipeline of Vitiligo Treatment

    • AbbVie reiterated commitment to pores and skin ailment studies, which includes vitiligo, at EADV 2022. Glimpses on their website hinted at a RoRT inhibitor have a look at for immune problems. 2023 IIS Strategic Priorities label vitiligo as "Non-Product Only."
    • Ahammune Biosciences Pvt. Ltd., Pune-primarily based, pioneers AB1001 for early vitiligo tiers, targeting T-cell activation. Phase I trials finished in January 2023.
    • Applied Biology's Photocil mimics phototherapy, acquired via Jupiter Wellness in July 2022, renamed PhotoFirst after India's CDSCO approval in November 2022.
    • Avita Medical's RECELL® System sprays autologous cells on vitiligo lesions, submitted for FDA approval in December 2022, following preliminary approval in 2018.
    • Edesa Biotech advances EB06 antibody with Health Canada's Phase 2 approval in February 2023. EB06 goals autoreactive T cells via CXCL10.
    • In October 2022, Incyte acquired Villaris Therapeutics, gaining rights to auremolimab (VM6) for vitiligo remedy, making ready for clinical trials in 2023.


    Personalized care drives the segmental vitiligo treatment market growth, meeting specific needs of patients with this form of the condition.

    By Type, Vitiligo Treatment Market is divided into Segmental and Non–Segmental. Segmental vitiligo treatment is the market fastest-growing segment, offering targeted solutions for localized depigmentation. The rising awareness of its unique characteristics propels its rapid expansion. Evolving medical advancements emphasize tailored therapies, reflecting a dynamic market. The segmental vitiligo treatment market is projected to sustain growth, catering to patients' specific needs in this form of the condition.


    Topical treatments hold a prominent position in the global vitiligo industry

    By Treatment Type, Vitiligo Treatment Market is segmented into Topical Treatments, Light Therapy, Surgical Procedures and Others. Topical treatments dominate the vitiligo industry due to their convenience, non-invasiveness, and efficacy in localized treatment. These encompass corticosteroids, calcineurin inhibitors, and vitamin D analogs, delivering precise outcomes. The preference for non-surgical approaches strengthens their popularity, aided by patient compliance and ease of use. Topical solutions are ideal for limited disease spread and milder interventions, while ongoing research and innovation ensure their continued leadership in addressing vitiligo's diverse severity levels.


    Growing demand for patient-centric care underscores ambulatory clinics' pivotal role in shaping the future of vitiligo treatment

    By End User, Vitiligo Treatment Market is segmented into Hospitals, Ambulatory Clinics and Others. Ambulatory clinics rapidly dominate the vitiligo sector, offering outpatient convenience, specialized treatments, and expert consultations. This growth caters to patients seeking effective solutions without hospitalization, aligning with the demand for non-invasive and personalized medical services. This trend fosters ambulatory clinics as a trusted choice, allowing patients to maintain routines. Easy access to targeted therapies and ongoing care adds to their popularity. Evolving with technology and innovative approaches, these clinics' upward trajectory is set to continue. The surge in demand for accessible, patient-centric care highlights the vital role of ambulatory clinics in shaping the future of vitiligo treatment.


    As trends evolve and industries progress, the United States is anticipated to retain its position as a significant market leader across vitiligo treatment sectors

    By Country, Global Vitiligo Treatment Market is segmented into United States, Canada, Mexico, Germany, U.K., France, Italy, Spain, Japan, China, Australia, India, Brazil, Saudi Arabia, Argentina, U.A.E, South Africa and Rest of World. The United States is set to dominate the vitiligo market in the near future. Driven by factors such as economic strength, technological advancements, and a well-established healthcare system, it is poised to hold the leading position. The country's substantial investments in diverse industries and its role as a research and development hub contribute to its projected market supremacy. With a considerable consumer base and evolving industry trends, the United States is expected to maintain its position as a primary player in the vitiligo treatment market for years to come.


    Key Player

    Incyte Corporation, Bristol-Myers Squibb, Clinuvel Pharmaceuticals Ltd, Astellaspharmainc, Baxter International Inc, Pfizer and Dr. Reddy’s Laboratories Ltd. are the some of the major companies that operate in the global vitiligo treatment market.


    Renub Research latest report “Vitiligo Treatment Market, Global Forecast by Type (Segmental, Non - Segmental), by Treatment Type (Topical Treatments , Light Therapy, Surgical Procedures, Others), by End-User (Hospitals, Ambulatory Clinics, Others), by Country (United States, Canada, Mexico, Germany, U.K., France, Italy, Spain, Japan, China, Australia, India, Brazil, Saudi Arabia, Argentina, U.A.E, South Africa and Rest of World), Vitiligo Pipe Line Drugs (ARN-4079, ATI-502, AX-1602, BOS-475, CCP-070, Cerdulatinib (RVT-502), HuABC-2, Abatacept, Topical Ruxolitinib, VLRX-001), Companies (Incyte Corporation, Bristol-Myers Squibb, Clinuvel Pharmaceuticals Ltd, Astellaspharmainc, Baxter International Inc, Pfizer and Dr. Reddy’s Laboratories Ltd)” provides a detailed analysis of Global Vitiligo Treatment Industry.

     

    Global Vitiligo Treatment Market Share, By Treatment Type (Percentage)

     

    global-vitiligo-market-share

     

    Note: The chart above shows dummy data and is only for illustration purposes. Please get in touch with us for the actual market size and trends.


    Country – Patient Numbers & Market has been covered from 18 viewpoints:

    1.    United States
    2.    Canada
    3.    Mexico
    4.    Germany
    5.    U.K.
    6.    France
    7.    Italy
    8.    Spain
    9.    Japan
    10.    China
    11.    Australia
    12.    India
    13.    Brazil
    14.    Saudi Arabia
    15.    Argentina
    16.    U.A.E
    17.    South Africa
    18.    Rest of World


    Country – Volume has been covered from 18 viewpoints:

    1.    United States
    2.    Canada
    3.    Mexico
    4.    Germany
    5.    U.K.
    6.    France
    7.    Italy
    8.    Spain
    9.    Japan
    10.    China
    11.    Australia
    12.    India
    13.    Brazil
    14.    Saudi Arabia
    15.    Argentina
    16.    U.A.E
    17.    South Africa
    18.    Rest of World


    Vitiligo Type – Market has been covered from 2 viewpoints:

    1.    Segmental
    2.    Non - segmental


    Treatment Type – Market has been covered from 4 viewpoints:

    1.    Topical Treatments
    2.    Light Therapy
    3.    Surgical Procedures
    4.    Others


    End User – Market has been covered from 4 viewpoints:

    1.    Hospitals
    2.    Ambulatory Clinics
    3.    Others


    Vitiligo Pipe Line Drugs market has been covered from 10 viewpoints:

    1.    ARN-4079
    2.    ATI-502
    3.    AX-1602
    4.    BOS-475
    5.    CCP-070
    6.    Cerdulatinib (RVT-502)
    7.    HuABC-2
    8.    Abatacept
    9.    Topical Ruxolitinib
    10.    VLRX-001


    Company Insight:

    •    Overview
    •    Recent Development
    •    Revenue


    Companies Covered:

    1.    Incyte Corporation
    2.    Bristol-Myers Squibb
    3.    Clinuvel Pharmaceuticals Ltd.
    4.    Astellaspharmainc
    5.    Baxter International Inc
    6.    Pfizer
    7.    Dr. Reddy’s Laboratories Ltd.

     

    Report Details:

    Report Features Details
    Base Year 2022
    Historical Period 2018 - 2022
    Forecast Period 2023 - 2028
    Market US$ Billion
    Segment Covered Countries, Type, Treatment Type, and End-User
    Countries Covered United States, Canada, Mexico, Germany, U.K., France, Italy, Spain, Japan, China, Australia, India, Brazil, Saudi Arabia, Argentina, U.A.E, South Africa and Rest of World
    Companies Covered Incyte Corporation, Bristol-Myers Squibb, Clinuvel Pharmaceuticals Ltd., Astellaspharmainc, Baxter International Inc, Pfizer and Dr. Reddy’s Laboratories Ltd.
    Customization Scope 20% Free Customization
    Post-Sale Analyst Support 1 Year (52 Weeks)
    Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)

    1.    Introduction

    2.    Research & Methodology

    3.    Executive Summary

    4.    Market Dynamics

    4.1    Growth Drivers
    4.2    Challenges


    5.    Global Vitiligo Patient Numbers & Market

    5.1    VitiligoTreatment Market
    5.2    Vitiligo Patients (Thousand)


    6.    Market Share - Global Vitiligo Patient Analysis

    6.1    Market Share

    6.1.1    Vitiligo Type
    6.1.2    Treatment Type
    6.1.3    End User
    6.1.4    Country Vitiligo Market Share

    6.2    Volume Share

    6.2.1    By Country Vitiligo Patient Numbers Share


    7.    Diseases Type – Global Vitiligo Market

    7.1    Segmental
    7.2    Non Segmental


    8.    Treatment Type - Global Vitiligo Market

    8.1    Topical Treatments
    8.2    Light Therapy
    8.3    Surgical Procedures
    8.4    Others


    9.    End User – Global Vitiligo Market

    9.1    Hospitals
    9.2    Ambulatory Clinics
    9.3    Others


    10.    Country – Vitiligo Patient Numbers & Market

    10.1    United States

    10.1.1    Vitiligo Market
    10.1.2    Vitiligo Patient (Thousand)

    10.2    Canada

    10.2.1    Vitiligo Market
    10.2.2    Vitiligo Patient (Thousand)

    10.3    Mexico

    10.3.1    Vitiligo Market
    10.3.2    Vitiligo Patient (Thousand)

    10.4    Germany

    10.4.1    Vitiligo Market
    10.4.2    Vitiligo Patient (Thousand)

    10.5    United Kingdom

    10.5.1    Vitiligo Market
    10.5.2    Vitiligo Patient (Thousand)

    10.6    France

    10.6.1    Vitiligo Market
    10.6.2    Vitiligo Patient (Thousand)

    10.7    Italy

    10.7.1    Vitiligo Market
    10.7.2    Vitiligo Patient (Thousand)

    10.8    Spain

    10.8.1    Vitiligo Market
    10.8.2    Vitiligo Patient (Thousand)

    10.9    Japan

    10.9.1    Vitiligo Market
    10.9.2    Vitiligo Patient (Thousand)

    10.10    China

    10.10.1    Vitiligo Market
    10.10.2    Vitiligo Patient (Thousand)

    10.11    Australia

    10.11.1    Vitiligo Market
    10.11.2    Vitiligo Patient (Thousand)

    10.12    India

    10.12.1    Vitiligo Market
    10.12.2    Vitiligo Patient (Thousand)

    10.13    Brazil

    10.13.1    Vitiligo Market
    10.13.2    Vitiligo Patient (Thousand)

    10.14    Saudi Arabia

    10.14.1    Vitiligo Market
    10.14.2    Vitiligo Patient (Thousand)

    10.15    Argentina

    10.15.1    Vitiligo Market
    10.15.2    Vitiligo Patient (Thousand)

    10.16    United Arab Emirates

    10.16.1    Vitiligo Market
    10.16.2    Vitiligo Patient (Thousand)

    10.17    South Africa

    10.17.1    Vitiligo Market
    10.17.2    Vitiligo Patient (Thousand)

    10.18    Rest of World

    10.18.1    Vitiligo Market
    10.18.2    Vitiligo Patient (Thousand)


    11.    Vitiligo Pipe Line Drugs

    11.1    ARN-4079
    11.2    ATI-502
    11.3    AX-1602
    11.4    BOS-475
    11.5    CCP-070
    11.6    Cerdulatinib (RVT-502)
    11.7    HuABC-2
    11.8    Abatacept
    11.9    Topical Ruxolitinib
    11.10    VLRX-001


    12.    Clinical Study of Vitiligo Market


    13.    Porter’s Five Forces

    13.1    Bargaining Power of Buyer
    13.2    Bargaining Power of Supplier
    13.3    Threat of New Entrants
    13.4    Rivalry among Existing Competitors
    13.5    Threat of Substitute Products


    14.    SWOT Analysis

    14.1    Strengths
    14.2    Weaknesses
    14.3    Opportunities
    14.4    Threats


    15.    Company Analysis

    15.1    Incyte Corporation

    15.1.1    Overviews
    15.1.2    Resent Development
    15.1.3    SWOT Analysis
    15.1.4    Revenue

    15.2    Bristol-Myers Squibb

    15.2.1    Overviews
    15.2.2    Resent Development
    15.2.3    SWOT Analysis
    15.2.4    Revenue

    15.3    Clinuvel Pharmaceuticals Ltd

    15.3.1    Overviews
    15.3.2    Resent Development
    15.3.3    SWOT Analysis
    15.3.4    Revenue

    15.4    Astellaspharmainc

    15.4.1    Overviews
    15.4.2    Resent Development
    15.4.3    SWOT Analysis
    15.4.4    Revenue

    15.5    Baxter International Inc.

    15.5.1    Overviews
    15.5.2    Resent Development
    15.5.3    SWOT Analysis
    15.5.4    Revenue

    15.6    Pfizer

    15.6.1    Overviews
    15.6.2    Resent Development
    15.6.3    SWOT Analysis
    15.6.4    Revenue

    15.7    Dr. Reddy’s Laboratories Ltd

    15.7.1    Overviews
    15.7.2    Resent Development
    15.7.3    SWOT Analysis
    15.7.4    Revenue


    List of Figures:

    Figure-01:    Global Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-02:    Global – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-03:    Global Vitiligo Patients Population Volume (Thousand), 2018 – 2022
    Figure-04:    Global – Forecast for Vitiligo Patients Population Volume (Thousand), 2023 – 2028
    Figure-05:    Diseases Type – Segmental Market (Million US$), 2018 – 2022
    Figure-06:    Diseases Type – Forecast for Segmental Market (Million US$), 2023 – 2028
    Figure-07:    Diseases Type – Non Segmental Market (Million US$), 2018 – 2022
    Figure-08:    Diseases Type – Forecast for Non Segmental Market (Million US$), 2023 – 2028
    Figure-09:    Treatment Type – Topical Treatments Market (Million US$), 2018 – 2022
    Figure-10:    Treatment Type – Forecast for Topical Treatments Market (Million US$), 2023 – 2028
    Figure-11:    Treatment Type – Light Therapy Market (Million US$), 2018 – 2022
    Figure-12:    Treatment Type – Forecast for Light Therapy Market (Million US$), 2023 – 2028
    Figure-13:    Treatment Type – Surgical Procedures Market (Million US$), 2018 – 2022
    Figure-14:    Treatment Type – Forecast for Surgical Procedures Market (Million US$), 2023 – 2028
    Figure-15:    Treatment Type – Others Market (Million US$), 2018 – 2022
    Figure-16:    Treatment Type – Forecast for Others Market (Million US$), 2023 – 2028
    Figure-17:    End User – Hospitals Market (Million US$), 2018 – 2022
    Figure-18:    End User – Forecast for Hospitals Market (Million US$), 2023 – 2028
    Figure-19:    End User – Ambulatory Clinics Market (Million US$), 2018 – 2022
    Figure-20:    End User – Forecast for Ambulatory Clinics Market (Million US$), 2023 – 2028
    Figure-21:    End User – Others Market (Million US$), 2018 – 2022
    Figure-22:    End User – Forecast for Others Market (Million US$), 2023 – 2028
    Figure-23:    United States – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-24:    United States – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-25:    United States – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-26:    United States – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-27:    Canada – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-28:    Canada – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-29:    Canada – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-30:    Canada – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-31:    Mexico – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-32:    Mexico – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-33:    Mexico – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-34:    Mexico – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-35:    Germany – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-36:    Germany – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-37:    Germany – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-38:    Germany – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-39:    United Kingdom – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-40:    United Kingdom – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-41:    United Kingdom – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-42:    United Kingdom – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-43:    France – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-44:    France – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-45:    France – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-46:    France – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-47:    Italy – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-48:    Italy – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-49:    Italy – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-50:    Italy – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-51:    Spain – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-52:    Spain – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-53:    Spain – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-54:    Spain – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-55:    Japan – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-56:    Japan – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-57:    Japan – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-58:    Japan – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-59:    China – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-60:    China – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-61:    China – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-62:    China – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-63:    Australia – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-64:    Australia – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-65:    Australia – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-66:    Australia – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-67:    India – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-68:    India – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-69:    India – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-70:    India – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-71:    Brazil – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-72:    Brazil – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-73:    Brazil – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-74:    Brazil – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-75:    Saudi Arabia – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-76:    Saudi Arabia – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-77:    Saudi Arabia – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-78:    Saudi Arabia – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-79:    Argentina – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-80:    Argentina – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-81:    Argentina – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-82:    Argentina – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-83:    United Arab Emirates – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-84:    United Arab Emirates – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-85:    United Arab Emirates – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-86:    United Arab Emirates – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-87:    South Africa – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-88:    South Africa – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-89:    South Africa – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-90:    South Africa – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-91:    Rest of World – Vitiligo Treatment Market (Million US$), 2018 – 2022
    Figure-92:    Rest of World – Forecast for Vitiligo Treatment Market (Million US$), 2023 – 2028
    Figure-93:    Rest of World – Vitiligo Treatment Patients Population Volume (Thousand), 2018 – 2022
    Figure-94:    Rest of World – Forecast for Vitiligo Treatment Patients Population Volume (Thousand), 2023 – 2028
    Figure-95:    Incyte Corporation – Global Revenue (Million US$), 2018 – 2022
    Figure-96:    Incyte Corporation – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-97:    Bristol-Myers Squibb – Global Revenue (Million US$), 2018 – 2022
    Figure-98:    Bristol-Myers Squibb – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-99:    Clinuvel Pharmaceuticals Limited – Global Revenue (Thousand US$), 2018 – 2022
    Figure-100:    Clinuvel Pharmaceuticals Limited – Forecast for Global Revenue (Thousand US$), 2023 – 2028
    Figure-101:    Astellas pharma Inc. – Global Revenue (Thousand US$), 2018 – 2022
    Figure-102:    Astellas pharma Inc. – Forecast for Global Revenue (Thousand US$), 2023 – 2028
    Figure-103:    Baxter International Inc. – Global Revenue (Thousand US$), 2018 – 2022
    Figure-104:    Baxter International Inc. – Forecast for Global Revenue (Thousand US$), 2023 – 2028
    Figure-105:    Pfizer – Global Revenue (Thousand US$), 2018 – 2022
    Figure-106:    Pfizer. – Forecast for Global Revenue (Thousand US$), 2023 – 2028
    Figure-107:    Dr. Reddy’s Laboratories Ltd – Global Revenue (Thousand US$), 2018 – 2022
    Figure-108:    Dr. Reddy’s Laboratories Ltd – Forecast for Global Revenue (Thousand US$), 2023 – 2028


    List of Tables:

    Table-01:    Global – Vitiligo Treatment Market Share by Vitiligo Type (Percent), 2018 – 2022
    Table-02:    Global – Forecast for Vitiligo Treatment Market Share by Vitiligo Type (Percent), 2023 – 2028
    Table-03:    Global – Vitiligo Treatment Market Share by Treatment Type (Percent), 2018 – 2022
    Table-04:    Global – Forecast for Vitiligo Treatment Market Share by Treatment Type (Percent), 2023 – 2028
    Table-05:    Global – Vitiligo Treatment Market Share by End-User (Percent), 2018 – 2022
    Table-06:    Global – Forecast for Vitiligo Treatment Market Share by End-User (Percent), 2023 – 2028
    Table-07:    Global – Vitiligo Treatment Market Share by Country (Percent), 2018 – 2022
    Table-08:    Global – Forecast for Vitiligo Treatment Market Share by Country (Percent), 2023 – 2028
    Table-09:    Global – Vitiligo Treatment Patient Numbers Share by Country (Percent), 2018 – 2022
    Table-10:    Global – Forecast for Vitiligo Treatment Patient Numbers Share by Country (Percent), 2023 – 2028

    • Description
      Price
    • Chapter 1 & 4     Pages : 4
      $200
    • Chapter 5     Pages : 4
      $200
    • Chapter 7     Pages : 4
      $200
    • Chapter 8     Pages : 8
      $300
    • Chapter 9     Pages : 6
      $300
    • Chapter 10.1     Pages : 4
      $200
    • Chapter 10.2     Pages : 4
      $200
    • Chapter 10.3     Pages : 4
      $200
    • Chapter 10.4     Pages : 4
      $200
    • Chapter 10.5     Pages : 4
      $200
    • Chapter 10.6     Pages : 4
      $200
    • Chapter 10.7     Pages : 4
      $200
    • Chapter 10.8     Pages : 4
      $200
    • Chapter 10.9     Pages : 4
      $200
    • Chapter 10.10     Pages : 4
      $200
    • Chapter 10.11     Pages : 4
      $200
    • Chapter 10.12     Pages : 4
      $200
    • Chapter 10.13     Pages : 4
      $200
    • Chapter 10.14     Pages : 4
      $200
    • Chapter 10.15     Pages : 4
      $200
    • Chapter 10.16     Pages : 4
      $200
    • Chapter 10.17     Pages : 4
      $200
    • Chapter 10.18     Pages : 4
      $200
    • Chapter 11     Pages : 10
      $400
    • Chapter 12     Pages : 2
      $200
    • Chapter 13     Pages : 5
      $150
    • Chapter 14     Pages : 4
      $150
    • Chapter 15.1     Pages : 6
      $150
    • Chapter 15.2     Pages : 6
      $150
    • Chapter 15.3     Pages : 6
      $150
    • Chapter 15.4     Pages : 6
      $150
    • Chapter 15.5     Pages : 6
      $150
    • Chapter 15.6     Pages : 6
      $150
    • Chapter 15.7     Pages : 6
      $150

    Related Reports